Jubilant LifeSciences joins other Indian pharma companies including Alembic to have received FDA approval for Itraconazole sales in the US. This is the generic version of Janssen's Sporanox, which is used to treat fungal infections. As of December 31, Jubilant has received 49 approvals out of the 73 ANDAs it has filed at the US FDA.